Oliver Bacon, MD, MPH

Associate Clinical Professor

  1. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis.
  2. Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco.
  3. Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
  4. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
  5. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.
  6. 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report.
  7. Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project.
  8. Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project.
  9. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
  10. Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.
  11. Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians.
  12. Commitment issues: PrEP adherence in injecting drug users.
  13. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
  14. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
  15. 007.5 Sexual risk behaviour and sexually transmitted diseases among men who have sex with men participating in a pre-exposure prophylaxis demonstration project.
  16. Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States.
  17. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
  18. HIV intervention for providers study: a randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people.
  19. Task shifting in Mozambique: cross-sectional evaluation of non-physician clinicians' performance in HIV/AIDS care.
  20. Detection of acute HIV infections in high-risk patients in California.
  21. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco.